Evidence map›Paper›PMID 38825435›Full record

ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2024

High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program.

Andrew Hendifar, Megan Hitchins, Marie Lauzon, Kathryn E Hatchell, Brandie Heald, Stephen Pandol, Anjaparavanda P Naren, Arsen Osipov

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrew HendifarSamuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles CA, USA. Electronic address: andrew.hendifar@cshs.org.
Megan HitchinsSamuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles CA, USA.
Marie LauzonSamuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles CA, USA.
Kathryn E HatchellInvitae, San Francisco, CA, USA.
Brandie HealdInvitae, San Francisco, CA, USA.
Stephen PandolCedars Sinai, Medicine, USA.
Anjaparavanda P NarenCedars Sinai, Medicine, USA.
Arsen OsipovSamuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles CA, USA.

Funding

Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes - Administrative SupplementU01DK108314 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Mark Goodarzi, Stephen J. Pandol · 2015 to 2026
$6.1M
NIDDK NIH HHS U01 DK108314
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Pancreatic DuctalCystic Fibrosis Transmembrane Conductance RegulatorGenetic Predisposition to DiseaseGenetic TestingGerm-Line MutationPancreatic NeoplasmsAdultAgedBiomarkers, TumorDNA Mutational AnalysisFemaleHumansMaleMiddle AgedPhenotypePredictive Value of TestsBiomarkers, TumorCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID38825435
PMCPMC11317177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.